Functional Fungi, With Little FDA Oversight, Are the New CBD

This week, consumer-goods reporter Leslie Patton takes a look at a group of mushrooms that’s increasingly being marketed for health properties. The products are rising in popularity. But is this a case of CBD 2.0?

Fungi such as reishi, lion’s mane and cordyceps are becoming buzzwords for wellness-obsessed Americans — and their rise mirrors that of CBD.